Cargando…
miR-625 reverses multidrug resistance in gastric cancer cells by directly targeting ALDH1A1
Background: microRNAs (miRNAs) are emerging as critical regulators of multidrug resistance (MDR) in gastric cancer, a major cause of chemotherapy failure. miR-625 is downregulated in gastric cancer and negatively associated with metastasis. In the current study, we aimed to investigate whether miR-6...
Autores principales: | Gong, Xufei, Xu, Baoli, Zi, Li, Chen, Xinrui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6643062/ https://www.ncbi.nlm.nih.gov/pubmed/31410057 http://dx.doi.org/10.2147/CMAR.S208708 |
Ejemplares similares
-
Crucial Roles of miR-625 in Human Cancer
por: Zhang, Menggang, et al.
Publicado: (2022) -
LINC00511 accelerated the process of gastric cancer by targeting miR-625-5p/NFIX axis
por: Chen, Zhaosheng, et al.
Publicado: (2019) -
miR-26a Reverses Multidrug Resistance in Osteosarcoma by Targeting MCL1
por: Li, Ming, et al.
Publicado: (2021) -
MiR-23b controls ALDH1A1 expression in cervical cancer stem cells
por: Wang, Weiwen, et al.
Publicado: (2017) -
CircLASP1 silence strengthens the therapeutic effects of MK‐2206 on nasopharyngeal cancer through upregulating miR‐625
por: Xu, Li‐Na, et al.
Publicado: (2023)